Alloantigen-stimulated anti-HIV activity

Blood

Volumn 92, Issue 9, 1998, Pages 3346-3354

  Pinto, Ligia A ^a   Sharpe, Sandra ^a   Cohen, David I ^a   Shearer, Gene M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ANTIVIRAL ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0032211160     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3346.421k40_3346_3354     Document Type: Article

References (42)

1. Stott EJ, Schild GC: Strategies for AIDS vaccines. J Antimicrob Chemother 37:185, 1996 (supple B)
2. Haynes BF: HIV vaccines: Where we are and where we are going. Lancet 348:933, 1996
3. Stott J: Anti-cell antibodies in macaques. Nature 353:393, 1991
4. Kiprov DD, Sheppard HW, Hanson CV: Alloiminimization to prevent AIDS. Science 263:737, 1994
5. Shearer GM, Clerici M, Dalgleish A: Alloimmunization as an AIDS vaccine? Science 262:161, 1993
6. Chan WL, Rodgers A, Hancock RD, Taffs F, Kitchin P, Farrar G, Liew FY: Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med 176:1203, 1992
7. Stott EJ, Chan WL, Mills KHG, Page M, Taffs F, Cranage M, Greenaway P, Kitchin P: Preliminary report: Protection of cynomolgous macaques against simian immunodeficiency virus by fixed infected cell vaccine. Lancet 336:1538, 1990
8. Chan WL, Rodgers A, Grief C, Almond N, Ellis S, Flanagan B, Silvera P, Bootman J, Stott J, Kent K, Bomford R: Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIV mac-32H. AIDS 9:223, 1995
9. Arthur LO, Bess JW, Urban RJ, Morton WR, Mann DL, Henderson LE, Benveniste RE: Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 69:3117, 1995
10. Arthur LO, Bless JW Jr, Sowder RC, Benveniste RE, Mann DL, Chermann J-C, Henderson LE: Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science 258:1935, 1992
11. Golding H, Shearer GM, Hillman K, Lucas P, Manischewitz J, Zajaz RA, Clerici M, Gress RE, Boswell RN, Golding B: Common epitope in human immunodeficiency virus (HIV) l-gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HTV-1 infected individuals. J Clin Invest 83:1430, 1989
12. Young JAT: HIV and HLA similarity. Nature 333:215, 1986
13. Hounsell EF, Renouf DV, Liney D, Dalgleish AG: A proposed molecular model for the carboxyl terminus of HIV-1 gp120 showing structural features consistent with the presence of a T cell alloepitope. Mol Aspects Med 12:28, 1991
14. Brühl P, Kerschbaum A, Zimmermann K, Eibl MM, Mannhalter JW: Allostimulated lymphocytes inhibit replication of HIV type I. AIDS Res Hum Retroviruses 12:31, 1996
15. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563, 1986
16. + cells involves a non-cytotoxic mechanism. J Virol 65:5921, 1991
17. + cells involves a noncytotoxic mechanism. J Virol 65:5921, 1991
18. + cell anti-HIV activity: Nonlytic suppression of virus replication. AIDS Res Hum Retroviruses 8:1039, 1992
19. + T cells. Immunol Today 17:217, 1996
20. + T cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-lα and MIP-lβ, suppress HIV-1 replication in monocyte/ macrophages. Proc Natl Acad Sci USA 93:15341, 1996 .
21. + T cells from HTV type l-seronegative individuals suppress virus replication in acutely infected cells. AIDS Res Hum Retroviruses 13:79, 1997
22. + T cells. Science 270:1811, 1995
23. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955, 1996
24. Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, Albert J, Wigzell H: Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci USA 93:15382, 1996
25. Zolla-Pazner S, O'Leary J, Burda S, Corny MK, Kim M, Mascola J, McCutchan F: Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J Virol 69:3807, 1995
26. Pinto LA, Sullivan J, Berzofsky JA, Clerici M, Kessler HA, Landay AL. Shearer GM: Env-specific cytotoxic T lymphocytes in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 96:867, 1995
27. Clerici M, Lucey DR, Zajac RA, Boswell RN, Gebel HM, Takahashi H, Berzofsky JA, Shearer GM: Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol 146:2214, 1991
28. Garboczi DN, Utz U, Ghosh P, Seth A, Kim J, VanTienhoven EAE, Biddison WE, Wiley DC: Assembly, specific binding, and crystallization of a human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J Immunol 157:5403, 1996
29. Masood R, Lunardi-Iskandar Y, Moudgil T, Zhang Y, Law RE, Huang C, Pun RK, Levine AM, Gill PS: IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun 202:374, 1994
30. Baier M, Werner A, Bannen N, Metzner K, Kurth R: HIV suppression by Interleukin-16. Nature 378:563, 1995
31. Shirazi Y, Pitha PM: Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T cells. Virology 193:303, 1993
32. Van't Wout AB, Kootstra NA, Mulder-Kampiga GA, Albrechtvan Lent, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, Schuitemaker H: Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral and vertical transmission. J Clin Invest 94:2060, 1994
33. Schuitemaker H, Koot M, Kootsra NA, Wouter-Dercksen M, de Goede REY, Van Steenwijk RP, Lange JMA, Eeftink-Schattenkerk JKM, Miedema F, Tersmette M: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T cell-tropic virus populations. J Virol 66:1354, 1992
34. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD: Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179, 1993
35. Tersmette M, de Goede REY, Al BJM, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F: Differential syncytiuminducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 62:2026, 1988
36. Tersmette M, Lange JMA, de Goede REY, de Wolf F, EeftinkSchattenkerk JKM, Schellenkens PTA, Coutinho RA, Huisman JG, Goudsmit J, Miedema F: Association between biological properties of human immunodeficiency virus variants and risk for AIDS mortality. Lancet 1:983, 1989
37. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in co-receptor use correlates with disease progression in HIV-infected individuals. J ExpMed 185:621, 1997
38. Simmons G, Wilkinson D, Reeves JD, Dittmar MT, Beddows S, Weber J, Carnegie G, Desselberger U, Gray PW, Weiss RA, Clapham PR: Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 70:7835, 1996
39. Kootstra N A, Miedema F, Schuitemaker H: Analysis of CD8+ T lymphocyte-mediated nonlytic suppression of autologous and heterologous primary human immunodeficiency virus type I isolates. AIDS Res Hum Retroviruses 13:685, 1997
40. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667, 1996
41. Deng H, Liu R, Ellmeier W, Choe S, Unutrnaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661, 1996
42. Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M: Identification of a chemokine receptor encoded by human cytomegalovirus as acofactorfor HIV-1 entry. Science 276:1874, 1997